Selective Activation of KCa3.1 and CRAC Channels by P2Y2 Receptors Promotes Ca2+ Signaling, Store Refilling and Migration of Rat Microglial Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ferreira, Roger ^a,b   Schlichter, Lyanne C ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; PURINERGIC P2Y2 RECEPTOR; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL KCA2.3; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL KCA3.1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM SIGNALING; CELL ACTIVATION; CELL DENSITY; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; MICROGLIA; NEUROTOXICITY; NONHUMAN; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; CALCIUM CHANNELS; CALCIUM SIGNALING; CELL LINE; CELL MOVEMENT; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; INTRACELLULAR SPACE; ION CHANNEL GATING; MICROGLIA; RATS; RECEPTORS, PURINERGIC P2Y2; URIDINE TRIPHOSPHATE;

RATTUS;

EID: 84876429703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062345     Document Type: Article

References (100)

1. Hanisch UK, Kettenmann H, (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
2. Inoue K, (2002) Microglial activation by purines and pyrimidines. Glia 40: 156-163.
3. Farber K, Kettenmann H, (2006) Purinergic signaling and microglia. Pflugers Arch 452: 615-621.
4. Hidetoshi T-S, Makoto T, Inoue K, (2012) P2Y receptors in microglia and neuroinflammation. WIREs Membr Transp Signal 1: 493-501.
5. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, et al. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9: 1512-1519.
6. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, et al. (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21: 1975-1982.
7. Ohsawa K, Kohsaka S, (2011) Dynamic motility of microglia: purinergic modulation of microglial movement in the normal and pathological brain. Glia 59: 1793-1799.
8. Farber K, Kettenmann H, (2006) Functional role of calcium signals for microglial function. Glia 54: 656-665.
9. McLarnon JG, (2005) Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res 81: 349-356.
10. Ohana L, Newell EW, Stanley EF, Schlichter LC, (2009) The Ca2+ release-activated Ca2+ current (ICRAC) mediates store-operated Ca2+ entry in rat microglia. Channels (Austin) 3: 129-139.
11. Siddiqui TA, Lively S, Vincent C, Schlichter LC, (2012) Regulation of podosome formation, microglial migration and invasion by Ca2+-signaling molecules expressed in podosomes. J Neuroinflammation 9: 250.
12. Kaushal V, Koeberle PD, Wang Y, Schlichter LC, (2007) The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J Neurosci 27: 234-244.
13. Schlichter LC, Kaushal V, Moxon-Emre I, Sivagnanam V, Vincent C, (2010) The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro. J Neuroinflammation 7: 4.
14. Liu BS, Ferreira R, Lively S, Schlichter LC, (2012) Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole. J Neuroimmune Pharmacol.
15. Cao YJ, Dreixler JC, Couey JJ, Houamed KM, (2002) Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur J Pharmacol 449: 47-54.
16. Sivagnanam V, Zhu X, Schlichter LC, (2010) Dominance of E. coli phagocytosis over LPS in the inflammatory response of microglia. J Neuroimmunol 227: 111-119.
17. Zhou W, Cayabyab FS, Pennefather PS, Schlichter LC, DeCoursey TE, (1998) HERG-like K+ channels in microglia. J Gen Physiol 111: 781-794.
18. Cayabyab FS, Khanna R, Jones OT, Schlichter LC, (2000) Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation. Eur J Neurosci 12: 1949-1960.
19. Cayabyab FS, Schlichter LC, (2002) Regulation of an ERG K+ current by Src tyrosine kinase. J Biol Chem 277: 13673-13681.
20. Cayabyab FS, Tsui FW, Schlichter LC, (2002) Modulation of the ERG K+ current by the tyrosine phosphatase, SHP-1. J Biol Chem 277: 48130-48138.
21. Schlichter LC, Mertens T, Liu B, (2011) Swelling activated Cl- channels in microglia: Biophysics, pharmacology and role in glutamate release. Channels (Austin) 5: 128-137.
22. Newell EW, Schlichter LC, (2005) Integration of K+ and Cl- currents regulate steady-state and dynamic membrane potentials in cultured rat microglia. J Physiol 567: 869-890.
23. Schlichter LC, Sakellaropoulos G, Ballyk B, Pennefather PS, Phipps DJ, (1996) Properties of K+ and Cl- channels and their involvement in proliferation of rat microglial cells. Glia 17: 225-236.
24. Jiang X, Newell EW, Schlichter LC, (2003) Regulation of a TRPM7-like current in rat brain microglia. J Biol Chem 278: 42867-42876.
25. Grynkiewicz G, Poenie M, Tsien RY, (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
26. Vincent C, Siddiqui TA, Schlichter LC, (2012) Podosomes in migrating microglia: components and matrix degradation. J Neuroinflammation 9: 190.
27. von Kugelgen I, (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
28. Parekh AB, (2010) Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 9: 399-410.
29. Peinelt C, Lis A, Beck A, Fleig A, Penner R, (2008) 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J Physiol 586: 3061-3073.
30. He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL, (2005) A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem 280: 10997-11006.
31. Takezawa R, Cheng H, Beck A, Ishikawa J, Launay P, et al. (2006) A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol 69: 1413-1420.
32. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K, (1997) 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem 122: 498-505.
33. DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW Jr, (2008) Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283: 19265-19273.
34. Tsien RY, (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19: 2396-2404.
35. Gyoneva S, Orr AG, Traynelis SF, (2009) Differential regulation of microglial motility by ATP/ADP and adenosine. Parkinsonism Relat Disord 15Suppl 3: S195-199.
36. Inoue K, (2008) Purinergic systems in microglia. Cell Mol Life Sci 65: 3074-3080.
37. Jacobson KA, Boeynaems JM, (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 15: 570-578.
38. Jacobson KA, Ivanov AA, de Castro S, Harden TK, Ko H, (2009) Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal 5: 75-89.
39. Parekh AB, Putney JW Jr, (2005) Store-operated calcium channels. Physiol Rev 85: 757-810.
40. Prakriya M, Lewis RS, (2003) CRAC channels: activation, permeation, and the search for a molecular identity. Cell Calcium 33: 311-321.
41. Moller T, (2002) Calcium signaling in microglial cells. Glia 40: 184-194.
42. Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, et al. (2001) Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 276: 12249-12256.
43. Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, Schlichter LC, (1999) hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J Biol Chem 274: 14838-14849.
44. Gao YD, Hanley PJ, Rinne S, Zuzarte M, Daut J, (2010) Calcium-activated K+ channel (KCa3.1) activity during Ca2+ store depletion and store-operated Ca2+ entry in human macrophages. Cell Calcium 48: 19-27.
45. Khanna R, Roy L, Zhu X, Schlichter LC, (2001) K+ channels and the microglial respiratory burst. Am J Physiol Cell Physiol 280: C796-806.
46. Hede SE, Amstrup J, Klaerke DA, Novak I, (2005) P2Y2 and P2Y4 receptors regulate pancreatic Ca2+-activated K+ channels differently. Pflugers Arch 450: 429-436.
47. Sonkusare SK, Bonev AD, Ledoux J, Liedtke W, Kotlikoff MI, et al. (2012) Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. Science 336: 597-601.
48. Adelman JP, Maylie J, Sah P, (2012) Small-conductance Ca2+-activated K+ channels: form and function. Annu Rev Physiol 74: 245-269.
49. Engbers JD, Anderson D, Asmara H, Rehak R, Mehaffey WH, et al. (2012) Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells. Proc Natl Acad Sci U S A 109: 2601-2606.
50. Kurpius D, Nolley EP, Dailey ME, (2007) Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 55: 873-884.
51. Yao J, Harvath L, Gilbert DL, Colton CA, (1990) Chemotaxis by a CNS macrophage, the microglia. J Neurosci Res 27: 36-42.
52. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, et al. (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795.
53. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, et al. (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461: 282-286.
54. Brundage RA, Fogarty KE, Tuft RA, Fay FS, (1991) Calcium gradients underlying polarization and chemotaxis of eosinophils. Science 254: 703-706.
55. Komuro H, Rakic P, (1998) Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations. J Neurobiol 37: 110-130.
56. Wei C, Wang X, Chen M, Ouyang K, Song LS, et al. (2009) Calcium flickers steer cell migration. Nature 457: 901-905.
57. Wei C, Wang X, Zheng M, Cheng H, (2012) Calcium gradients underlying cell migration. Curr Opin Cell Biol 24: 254-261.
58. Schwab A, Schuricht B, Seeger P, Reinhardt J, Dartsch PC, (1999) Migration of transformed renal epithelial cells is regulated by K+ channel modulation of actin cytoskeleton and cell volume. Pflugers Arch 438: 330-337.
59. Yang S, Zhang JJ, Huang XY, (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124-134.
60. Schaff UY, Dixit N, Procyk E, Yamayoshi I, Tse T, et al. (2010) Orai1 regulates intracellular calcium, arrest, and shape polarization during neutrophil recruitment in shear flow. Blood 115: 657-666.
61. Schmidt EM, Munzer P, Borst O, Kraemer BF, Schmid E, et al. (2011) Ion channels in the regulation of platelet migration. Biochem Biophys Res Commun 415: 54-60.
62. Schwab A, Nechyporuk-Zloy V, Gassner B, Schulz C, Kessler W, et al. (2011) Dynamic redistribution of calcium sensitive potassium channels (hKCa3.1) in migrating cells. J Cell Physiol 227: 686-696.
63. Schwab A, Wulf A, Schulz C, Kessler W, Nechyporuk-Zloy V, et al. (2006) Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J Cell Physiol 206: 86-94.
64. Schilling T, Stock C, Schwab A, Eder C, (2004) Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci 19: 1469-1474.
65. Jensen BS, Strobaek D, Olesen SP, Christophersen P, (2001) The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments? Curr Drug Targets 2: 401-422.
66. Pedarzani P, Stocker M, (2008) Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain. Cell Mol Life Sci 65: 3196-3217.
67. Wulff H, Zhorov BS, (2008) K+ channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev 108: 1744-1773.
68. Grissmer S, Nguyen AN, Cahalan MD, (1993) Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology. J Gen Physiol 102: 601-630.
69. Mahaut-Smith MP, Schlichter LC, (1989) Ca2+-activated K+ channels in human B lymphocytes and rat thymocytes. J Physiol 415: 69-83.
70. Joiner WJ, Wang LY, Tang MD, Kaczmarek LK, (1997) hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci U S A 94: 11013-11018.
71. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, et al. (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273: 1709-1714.
72. Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, et al. (1998) Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395: 503-507.
73. Zhang M, Abrams C, Wang L, Gizzi A, He L, et al. (2012) Structural basis for calmodulin as a dynamic calcium sensor. Structure 20: 911-923.
74. Keen JE, Khawaled R, Farrens DL, Neelands T, Rivard A, et al. (1999) Domains responsible for constitutive and Ca2+-dependent interactions between calmodulin and small conductance Ca2+-activated potassium channels. J Neurosci 19: 8830-8838.
75. Grunnet M, Jespersen T, Angelo K, Frokjaer-Jensen C, Klaerke DA, et al. (2001) Pharmacological modulation of SK3 channels. Neuropharmacology 40: 879-887.
76. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, et al. (2009) Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75: 281-295.
77. Allen D, Fakler B, Maylie J, Adelman JP, (2007) Organization and regulation of small conductance Ca2+-activated K+ channel multiprotein complexes. J Neurosci 27: 2369-2376.
78. Bildl W, Strassmaier T, Thurm H, Andersen J, Eble S, et al. (2004) Protein kinase CK2 is coassembled with small conductance Ca2+-activated K+ channels and regulates channel gating. Neuron 43: 847-858.
79. von Hahn T, Thiele I, Zingaro L, Hamm K, Garcia-Alzamora M, et al. (2001) Characterisation of the rat SK4/IK1 K+ channel. Cell Physiol Biochem 11: 219-230.
80. Hayashi M, Kunii C, Takahata T, Ishikawa T, (2004) ATP-dependent regulation of SK4/IK1-like currents in rat submandibular acinar cells: possible role of cAMP-dependent protein kinase. Am J Physiol Cell Physiol 286: C635-646.
81. Gerlach AC, Gangopadhyay NN, Devor DC, (2000) Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1. J Biol Chem 275: 585-598.
82. Gerlach AC, Syme CA, Giltinan L, Adelman JP, Devor DC, (2001) ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain. J Biol Chem 276: 10963-10970.
83. Neylon CB, D'Souza T, Reinhart PH, (2004) Protein kinase A inhibits intermediate conductance Ca2+-activated K+ channels expressed in Xenopus oocytes. Pflugers Arch 448: 613-620.
84. Balut CM, Hamilton KL, Devor DC, (2012) Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca2+-activated K+ channels: a novel target for medicinal chemistry efforts? ChemMedChem 7: 1741-1755.
85. Klein H, Garneau L, Trinh NT, Prive A, Dionne F, et al. (2009) Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. Am J Physiol Cell Physiol 296: C285-295.
86. Wulf A, Schwab A, (2002) Regulation of a calcium-sensitive K+ channel (cIK1) by protein kinase C. J Membr Biol. 187: 71-79.
87. Srivastava S, Li Z, Lin L, Liu G, Ko K, et al. (2005) The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1. Mol Cell Biol 25: 3630-3638.
88. Srivastava S, Li Z, Ko K, Choudhury P, Albaqumi M, et al. (2006) Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol Cell 24: 665-675.
89. Srivastava S, Zhdanova O, Di L, Li Z, Albaqumi M, et al. (2008) Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1. Proc Natl Acad Sci U S A 105: 14442-14446.
90. Faber ES, (2009) Functions and modulation of neuronal SK channels. Cell Biochem Biophys 55: 127-139.
91. Barmeyer C, Rahner C, Yang Y, Sigworth FJ, Binder HJ, et al. (2010) Cloning and identification of tissue-specific expression of KCNN4 splice variants in rat colon. Am J Physiol Cell Physiol 299: C251-263.
92. Ohya S, Niwa S, Yanagi A, Fukuyo Y, Yamamura H, et al. (2011) Involvement of dominant-negative spliced variants of the intermediate conductance Ca2+-activated K+ channel, KCa3.1, in immune function of lymphoid cells. J Biol Chem 286: 16940-16952.
93. Cahalan MD, Chandy KG, (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231: 59-87.
94. Edwards G, Feletou M, Weston AH, (2010) Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 459: 863-879.
95. Grgic I, Kaistha BP, Hoyer J, Kohler R, (2009) Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 157: 509-526.
96. Kohler R, Kaistha BP, Wulff H, (2010) Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin Ther Targets 14: 143-155.
97. Lam J, Wulff H, (2011) The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression. Drug Dev Res 72: 573-584.
98. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V, (2007) Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14: 1437-1457.
99. Bond CT, Maylie J, Adelman JP, (2005) SK channels in excitability, pacemaking and synaptic integration. Curr Opin Neurobiol 15: 305-311.
100. Eder C, (2010) Ion channels in monocytes and microglia/brain macrophages: promising therapeutic targets for neurological diseases. J Neuroimmunol 224: 51-55.